Preliminary trials demonstrate that the compound – a dual stimulator of GLP-1 and a related hormone receptors – may provide a significant breakthrough in body management programs . Unlike existing medications , the peptide seems to affect food intake and metabolic burn through multiple pathways . Despite additional investigation is essential, t